Oligonucleotide-Based Theraputics Summit 2025
DECEMBER 9-11, 2025
BOSTON, MA
Visit us at BOOTH #
We look forward to meeting you at Hotel Commonwealth in Boston, Massachusetts.
Request a meeting with our team at the Oligonucleotide-Based Therapeutics Summit to learn how we help our clients advance their therapeutic drug programs.
BioAgilytix will be presenting...
Customized approaches to support your bioanalytical needs
Working with an experienced bioanalytical provider like BioAgilytix is a critical step to a successful preclinical and clinical approach for your oligonucleotide therapy. Source multiple endpoints with just one service provider for your immunoassay, cell-based, molecular, and LC/MS assay development, validation, and sample testing. This approach helps ensure efficient data delivery for your therapeutic study.
PK Assays for RNA-based Therapeutics
Our scientific teams are well-versed in the unique methods and analytical platforms required for the detection of nucleic acid-based therapeutics during both preclinical and clinical testing. Commonly utilized techniques include:
- RT PCR (qPCR or ddPCR) for absolute and relative quantitation
- Hybridization ELISAs
- Ligand Binding Assays
- LC/MS methods
Comprehensive Suite of Bioanalytical Platforms
Premier suite of bioanalytical platforms to ensure the delivery of precise, robust, and reliable results for a wide range of assessments.
- qPCR/ddPCR
- ELISA
- LC/MS
- Flow cytometry
- MSD
Schedule a meeting with our experts on site
Learn how the combination of world-class scientific expertise, outstanding project management, and key regulatory insight can streamline our support for your therapeutic.
About the event
The Oligonucleotide-Based Therapeutics Summit is a focused, science-driven forum bringing together researchers, developers, and industry leaders advancing next-generation RNA and DNA medicines. The meeting centers on the discovery, design, and optimization of antisense oligonucleotides, siRNA, mRNA-based therapeutics, gene-modifying technologies, and emerging oligo platforms—creating a collaborative space for sharing breakthroughs and addressing development challenges.
The program spans key areas across the oligo development lifecycle, including innovative analytical methods, CMC considerations, delivery strategies, regulatory expectations, and real-world case studies. With its highly engaged, cross-disciplinary community, the Summit has become an important venue for elevating the science and strategy behind oligonucleotide-based therapeutics and for shaping the future of this rapidly evolving field.
To learn more about this event on their website.
Schedule a meeting with our experts on site
Speak with our team about how the combination of world-class scientific expertise, outstanding project management, and superior regulatory insight can expedite your advanced therapeutic. You can also fill out the form, and an expert will reach out to schedule a meeting with you onsite.
© Copyright 2026 BioAgilytix Labs. All rights reserved.
